ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 93 filers reported holding ADMA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 5.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,076,737 | -10.8% | 300,764 | -8.1% | 0.01% | 0.0% |
| Q2 2023 | $1,207,452 | +159.1% | 327,223 | +132.4% | 0.01% | +166.7% |
| Q1 2023 | $465,992 | -1.7% | 140,783 | +15.3% | 0.00% | 0.0% |
| Q4 2022 | $473,868 | -18.4% | 122,131 | -61.5% | 0.00% | -40.0% |
| Q1 2022 | $581,000 | +119.2% | 317,542 | +69.1% | 0.01% | +66.7% |
| Q4 2021 | $265,000 | +165.0% | 187,800 | +200.6% | 0.00% | +200.0% |
| Q2 2021 | $100,000 | +31.6% | 62,484 | +44.3% | 0.00% | 0.0% |
| Q1 2021 | $76,000 | +322.2% | 43,300 | +610.3% | 0.00% | – |
| Q1 2020 | $18,000 | – | 6,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |